A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer

NCT02225093 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of Dextromethorphan
Pharmacokinetics of Caffeine
Prostate Cancer

Interventions

DRUG: Caffeine
DRUG: Dextromethorphan
DRUG: Enzalutamide
DRUG: Enzalutamide Placebo to Match (PTM)

Sponsor

Astellas Pharma Europe B.V.

Collaborators

[object Object]